Expanding the genetic and clinical spectrum of osteogenesis imperfecta: identification of novel rare pathogenic variants in type I collagen-encoding genes.

autosomal recessive OI collagen type one molecular diagnosis of OI next generation sequencing (NGS) osteogenesis imperfecta (OI)

Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 07 07 2023
accepted: 11 09 2023
medline: 7 11 2023
pubmed: 6 11 2023
entrez: 6 11 2023
Statut: epublish

Résumé

Osteogenesis imperfecta (OI) is a clinically and genetically heterogeneous skeletal disorder. The majority of affected cases are attributed to autosomal dominant pathogenic variants (PVs) found in the In this study, we present the results of next-generation sequencing (NGS) analysis using a custom panel of 11 genes known to be associated with OI. This clinical study enrolled a total of 10 patients, comprising 7 male and 3 female patients from 7 families, all from the Puglia Region in South Italy, providing a detailed overview of their age, gender, family history, OI type, and non-skeletal features. The genetic analysis revealed 5 PVs in the The identification of these previously unreported PVs expands the variant spectrum of the

Identifiants

pubmed: 37929041
doi: 10.3389/fendo.2023.1254695
pmc: PMC10623311
doi:

Substances chimiques

Collagen Type I, alpha2 Subunit 0
Collagen Type I 0
Collagen Type I, alpha 1 Chain 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1254695

Informations de copyright

Copyright © 2023 Paduano, Fischetto, Moretti, De Vito and Tatullo.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Bone Rep. 2021 Jul 26;15:101110
pubmed: 34381850
Endocr Dev. 2015;28:196-209
pubmed: 26138843
Am J Hum Genet. 2009 Oct;85(4):521-7
pubmed: 19781681
Bonekey Rep. 2013 Dec 04;2:456
pubmed: 24501682
N Engl J Med. 2010 Feb 11;362(6):521-8
pubmed: 20089953
Eur J Med Genet. 2020 Jun;63(6):103896
pubmed: 32081708
Am J Hum Genet. 2013 Apr 4;92(4):590-7
pubmed: 23499310
Am J Hum Genet. 2010 Apr 9;86(4):551-9
pubmed: 20362275
Hum Mutat. 1996;7(2):89-99
pubmed: 8829649
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Mol Med Rep. 2016 Nov;14(5):4918-4926
pubmed: 27748872
Front Genet. 2019 Aug 09;10:722
pubmed: 31447884
Mol Genet Genomic Med. 2020 Sep;8(9):e1366
pubmed: 32588564
Oral Dis. 2017 Jan;23(1):42-49
pubmed: 27510842
Am J Hum Genet. 2012 Aug 10;91(2):349-57
pubmed: 22863195
Hum Genomics. 2017 Aug 15;11(1):19
pubmed: 28810924
Am J Hum Genet. 2013 Apr 4;92(4):565-74
pubmed: 23499309
Matrix Biol. 2000 Feb;19(1):1-9
pubmed: 10686420
Hum Genomics. 2016 Aug 12;10(1):27
pubmed: 27519266
Sci Rep. 2016 Jun 23;6:28417
pubmed: 27335225
Am J Med Genet A. 2014 Jun;164A(6):1470-81
pubmed: 24715559
PLoS One. 2017 May 12;12(5):e0176466
pubmed: 28498836
J Bone Miner Res. 2010 Jun;25(6):1367-74
pubmed: 19929435
Annu Rev Biochem. 2009;78:929-58
pubmed: 19344236
Methods Enzymol. 1987;145:223-35
pubmed: 3474490
Biochemistry. 1993 Nov 2;32(43):11688-95
pubmed: 8218237
J Bone Miner Metab. 2012 Jan;30(1):69-77
pubmed: 21667357
J Biol Chem. 1991 Feb 5;266(4):2590-4
pubmed: 1990009
Bone. 1994 May-Jun;15(3):321-8
pubmed: 7520724
Hum Mutat. 2015 Jul;36(7):728-39
pubmed: 25963598
Eur J Hum Genet. 2015 Aug;23(8):1042-50
pubmed: 25944380
J Bone Miner Res. 2011 Dec;26(12):2798-803
pubmed: 21826736
Hum Mutat. 2007 Mar;28(3):209-21
pubmed: 17078022
Biochim Biophys Acta. 2013 Nov;1833(11):2479-91
pubmed: 23602968
Nature. 2020 Jul;583(7814):96-102
pubmed: 32581362
Osteoporos Int. 2016 Dec;27(12):3607-3613
pubmed: 27509835
J Bone Miner Metab. 2020 Mar;38(2):188-197
pubmed: 31414283
Eur J Pediatr. 1995 Feb;154(2):123-9
pubmed: 7720740
Am J Hum Genet. 2011 Mar 11;88(3):362-71
pubmed: 21353196
Am J Med Genet C Semin Med Genet. 2016 Dec;172(4):367-383
pubmed: 27813341
Orphanet J Rare Dis. 2020 May 27;15(1):128
pubmed: 32460820
Eur J Hum Genet. 2019 Jul;27(7):1090-1100
pubmed: 30886339
Orphanet J Rare Dis. 2011 Dec 29;6:88
pubmed: 22206639
Front Genet. 2021 Jul 09;12:692978
pubmed: 34306033
Hum Mutat. 2012 Dec;33(12):1697-707
pubmed: 22753364
Science. 1994 Oct 7;266(5182):75-81
pubmed: 7695699
Am J Hum Genet. 1998 Jan;62(1):98-110
pubmed: 9443882
Lancet. 2016 Apr 16;387(10028):1657-71
pubmed: 26542481
Nucleic Acids Res. 1997 Jan 1;25(1):181-7
pubmed: 9016532
Lancet. 2004 Apr 24;363(9418):1377-85
pubmed: 15110498

Auteurs

Francesco Paduano (F)

Stem Cells and Medical Genetics Units, Tecnologica Research Institute and Marrelli Health, Crotone, Italy.

Rita Fischetto (R)

Metabolic and Genetic Diseases Unit, "Giovanni XXIII" Hospital, Bari, Italy.

Biagio Moretti (B)

Orthopaedic and Traumathogic Unit General Hospital Policlinico, Department of Translational Biomedicine and Neuroscience, University "Aldo Moro" of Bari, Bari, Italy.

Danila De Vito (D)

Department of Translational Biomedicine and Neuroscience, Medical School, University "Aldo Moro" of Bari, Bari, Italy.

Marco Tatullo (M)

Department of Translational Biomedicine and Neuroscience, Medical School, University "Aldo Moro" of Bari, Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH